来自疾病预防控制中心的特别报告:抗抑郁药亚类在社区居住的美国老年人中的使用与跌倒风险。

Special Report from the CDC Antidepressant subclass use and fall risk in community-dwelling older Americans.

机构信息

Division of Injury Prevention, National Center of Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Division of Injury Prevention, National Center of Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, USA.

出版信息

J Safety Res. 2021 Feb;76:332-340. doi: 10.1016/j.jsr.2020.11.008. Epub 2020 Dec 13.

Abstract

INTRODUCTION

Falls among older adults are a significant health concern affecting more than a quarter of older adults (age 65+). Certain fall risk factors, such as medication use, increase fall risk among older adults (age 65+).

AIM

The aim of this study is to examine the association between antidepressant-medication subclass use and self-reported falls in community-dwelling older adults.

METHODS

This analysis used the 2009-2013 Medicare Current Beneficiary Survey, a nationally representative panel survey. A total of 8,742 community-dwelling older adults, representing 40,639,884 older Medicare beneficiaries, were included. We compared self-reported falls and psychoactive medication use, including antidepressant subclasses. These data are controlled for demographic, functional, and health characteristics associated with increased fall risk. Descriptive analyses and multivariate logistic regression analyses were conducted using SAS 9.4 and Stata 15 software.

RESULTS

The most commonly used antidepressant subclass were selective serotonin reuptake inhibitors (SSRI) antidepressants (13.1%). After controlling for characteristics associated with increased fall risk (including depression and concurrent psychoactive medication use), the risk of falling among older adults increased by approximately 30% among those who used a SSRI or a serotonin-norepinephrine reuptake inhibitors (SNRI) compared to non-users. The adjusted risk ratio (aRR) for SSRI was 1.29 (95% CI = 1.13, 1.47) and for SNRI was 1.32 (95% CI = 1.07, 1.62).

CONCLUSION

SSRI and SNRI are associated with increased risk of falling after adjusting for important confounders. Medication use is a modifiable fall risk factor in older adults and can be targeted to reduce risk of falls. Practical Applications: Use of selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors increased the risk of falling in older adults by approximately 30%, even after controlling for demographic, functional, and health characteristics, including depression. Health care providers can work towards reducing fall risk among their older patients by minimizing the use of certain medications when potential risks outweigh the benefits.

摘要

介绍

老年人跌倒对健康构成严重威胁,影响超过四分之一的老年人(年龄在 65 岁以上)。某些跌倒风险因素,如药物使用,会增加老年人(年龄在 65 岁以上)的跌倒风险。

目的

本研究旨在探讨抗抑郁药亚类使用与社区居住的老年人自我报告跌倒之间的关联。

方法

本分析使用了 2009-2013 年医疗保险当前受益人调查,这是一项具有全国代表性的小组调查。共有 8742 名社区居住的老年人,代表 40639884 名老年医疗保险受益人,包括在内。我们比较了自我报告的跌倒和精神活性药物使用情况,包括抗抑郁药亚类。这些数据控制了与跌倒风险增加相关的人口统计学、功能和健康特征。使用 SAS 9.4 和 Stata 15 软件进行描述性分析和多变量逻辑回归分析。

结果

最常用的抗抑郁药亚类是选择性 5-羟色胺再摄取抑制剂(SSRIs)抗抑郁药(13.1%)。在控制与跌倒风险增加相关的特征(包括抑郁和同时使用精神活性药物)后,与非使用者相比,使用 SSRIs 或去甲肾上腺素-5-羟色胺再摄取抑制剂(SNRIs)的老年人跌倒风险增加了约 30%。SSRIs 的调整风险比(aRR)为 1.29(95%CI=1.13,1.47),SNRIs 的 aRR 为 1.32(95%CI=1.07,1.62)。

结论

在调整重要混杂因素后,SSRIs 和 SNRIs 与跌倒风险增加相关。药物使用是老年人跌倒的可改变风险因素,可以针对降低跌倒风险。

实际应用

即使在控制人口统计学、功能和健康特征(包括抑郁)后,使用选择性 5-羟色胺再摄取抑制剂和去甲肾上腺素-5-羟色胺再摄取抑制剂也会使老年人跌倒的风险增加约 30%。医疗保健提供者可以通过在潜在风险超过收益时尽量减少某些药物的使用,努力降低其老年患者的跌倒风险。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索